Form 4 for CARL CARLSMED, INC.
Accepted 2025-07-24 00:00:00 ET · period of report 2025-07-22 · accession 0000950170-25-098544 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-24 | 2025-07-24 | CARL | Cordonnier Michael | CEO, Pres, Dir | M - OptEx | — | +3,612 | 1.24M | +0.3% | — |
| D | 2025-07-24 | 2025-07-22 | CARL | Cordonnier Michael | CEO, Pres, Dir | A - Grant | $0.00 | +142.9K | 726.2K | +24% | $0 |
| D | 2025-07-24 | 2025-07-24 | CARL | Cordonnier Michael | CEO, Pres, Dir | C - Cnv Deriv | — | -3,612 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-24 | M | A | 3,612 | — | 1,239,330 | D | — | — | (F1) These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date. |
| 2 | Derivative | Stock Options (Right to Buy) | 2025-07-22 | A | A | 142,857 | $0.00 | 726,235 | D | $15.00 · — to 2035-07-09 | 142,857 Common Stock | (F2) The unvested stock options are convertible into approximately 142,857 shares of the Issuer's common stock and will begin to vest in equal installments on each quarterly anniversary of July 22, 2025 (the "Grant Date"), such that all of the stock options will be vested on the fourth anniversary of the Grant Date, provided that the Reporting Person remains in continuous service through each applicable vesting date. |
| 3 | Derivative | Series B Preferred Stock | 2025-07-24 | C | D | 3,612 | — | 0 | D | — · — to — | 3,612 Common Stock | (F1) These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date. |